Suppr超能文献

可降解淀粉微球治疗肝脏肿瘤的实验与临床研究:第一部分。实验研究

[Experimental and clinical studies of degradable starch microspheres in the treatment of hepatic neoplasm: Part 1. Experimental study].

作者信息

Yamada T

机构信息

Department of Radiology, Osaka City University, School of Medicine.

出版信息

Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Aug;55(9):663-9.

PMID:7478952
Abstract

An Experimental study was performed to evaluate arterial blood flow changes caused with the intra-arterial administration of degradable starch microspheres (DSM). Hemodynamic and histological changes caused by the intra-arterial administration of DSM were investigated in rabbit kidneys. The degree of blockade of arterial blood flow was correlated with the dose of DSM, and angiography reflected these changes reliably. Histological changes were also dependent on the dose of DSM. Less than 6mg administration had caused little or no histological change. However massive necrosis of the renal tubules had been found with more than 15mg of DSM administration. The degree of blockade of arterial blood flow and histological change could be controlled by changes in the dose of DSM.

摘要

进行了一项实验研究,以评估动脉内注射可降解淀粉微球(DSM)引起的动脉血流变化。在兔肾中研究了动脉内注射DSM引起的血流动力学和组织学变化。动脉血流阻断程度与DSM剂量相关,血管造影能可靠地反映这些变化。组织学变化也取决于DSM剂量。注射少于6mg时几乎未引起组织学变化。然而,注射超过15mg DSM时发现肾小管大量坏死。动脉血流阻断程度和组织学变化可通过改变DSM剂量来控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验